CIK: 1910662 - Address: C/O Halozyme Therapeutics, Inc., 12390 El Camino Real, San Diego, CA 92130
10 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
2/20/24 18:53
2/16/24
HALOHalozyme Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagLabrosse NicoleCAOSVP,CFOM.d00.0001020615D
2/16/24 17:41
2/15/24
HALOHalozyme Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagLabrosse NicoleCAOSVP,CFOM.d00.00011311D
2/13/24 16:15
2/10/24
HALOHalozyme Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagLabrosse NicoleCAOSVP,CFOM.d00.00033310D
2/21/23 19:00
2/16/23
HALOHalozyme Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagLabrosse NicoleCAOSVP,CFOM.d00.00051289D
2/21/23 19:00
2/16/23
HALOHalozyme Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagLabrosse NicoleCAOSVP,CFOS.d-12449.260-3-229D
2/17/23 06:25
2/15/23
HALOHalozyme Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagLabrosse NicoleCAOSVP,CFOM.d00.0001246D
2/14/23 17:21
2/10/23
HALOHalozyme Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagLabrosse NicoleCAOSVP,CFOM.dm00.00041976D
11/16/22 19:51
11/15/22
HALOHalozyme Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagLabrosse NicoleCAOSVP,CFOS-26953.810-5-554D
2/17/22 18:03
2/15/22
HALOHalozyme Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagLabrosse NicoleCAOSVP,CFOM.d00.0001169D
2/14/22 19:28
2/10/22
HALOHalozyme Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagLabrosse NicoleCAOSVP,CFOM.dm00.00051678D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact